References
- Aarons, C.B., et al., 2007. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Annals of surgery, 245 (2), 176–184.
- Abe, Y., et al., 2012. Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast/myofibroblast apoptosis in the regeneration/healing process from TNBS-induced colitis. Digestive diseases and sciences, 57 (2), 335–344.
- Amento, E.P. and Beck, L.S., 1991. TGF-beta and wound healing. Ciba foundation symposium, 157, 115–123.
- Bokarewa, M., et al., 2005. Resistin, an adipokine with potent proinflammatory properties. The journal of immunology, 174 (9), 5789–5795.
- Bruun, J.M., et al., 2005. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. The journal of clinical endocrinology & metabolism, 90 (4), 2282–2289.
- Cancello, R., et al., 2006. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes, 55 (6), 1554–1561.
- Chae, G.N. and Kwak, S.J., 2003. NF-kappaB is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARgamma expression. Experimental & molecular medicine, 35 (5), 431–437.
- Chegini, N., 2008. TGF-β system: the principal profibrotic mediator of peritoneal adhesion formation. Seminars in reproductive medicine, 26 (4), 298–312.
- Chegini, N., et al., 2001. Differential expression of integrin αv and β3 in serosal tissue of human intraperitoneal organs and adhesion. Fertility and sterility, 75 (4), 791–796.
- Cigolini, M., et al., 1999. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-α? Atherosclerosis, 143 (1), 81–90.
- Dennler, S., et al., 1998. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene. The EMBO journal, 17 (11), 3091–3100.
- Dludla, P.V., et al., 2017. Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-beta-d-glucoside. Nutrition & metabolism, 14 (1), 45.
- Donnez, J., et al., 2016. Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis. Fertility and sterility, 106 (5), 1011–1017.
- Emanuela, F., et al., 2012. Inflammation as a link between obesity and metabolic syndrome. Journal of nutrition and metabolism, 2012, 1–7.
- Ergul, E. and Korukluoglu, B., 2008. Peritoneal adhesions: facing the enemy. International journal of surgery, 6 (3), 253–260.
- Eriksson, P., et al., 1998. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia, 41 (1), 65–71.
- Filippo, C.D., et al., 2006. Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesions. Mediators of inflammation, 2006, 1–4.
- Flanders, K., et al., 2008. Smad‐3 as a mediator of the fibrotic response. International journal of experimental pathology, 85 (1), A13.
- Fonseca-Alaniz, M.H., et al., 2007. Adipose tissue as an endocrine organ: from theory to practice. Journal de pediatria, 83 (5), 203.
- Fujita, K., et al., 2006. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circulation journal, 70 (11), 1437–1442.
- González-Périz, A. and Clària, J., 2010. Resolution of adipose tissue inflammation. The scientific world journal, 10, 832–856.
- Gregor, M.F. and Hotamisligil, G.S., 2011. Inflammatory mechanisms in obesity. Annual review of immunology, 29 (1), 415–445.
- Gu, L., et al., 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Molecular cell, 2 (2), 275–281.
- Haslinger, B., et al., 2002. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney international, 62 (5), 1611–1619.
- Haslinger, B., et al., 2003. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-α-activated human peritoneal mesothelial cells. Kidney international, 63 (6), 2065–2074.
- Haydont, V., et al., 2007. Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clinical cancer research, 13 (18), 5331–5340.
- Hocevar, B.A., Brown, T.L., and Howe, P.H., 1999. TGF-β induces fibronectin synthesis through ac‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway. The EMBO journal, 18 (5), 1345–1356.
- Holmdahl, L., et al., 1996. Fibrinolysis in human peritoneum during operation. Surgery, 119 (6), 701–705.
- Holmdahl, L., et al., 1998. Depression of peritoneal fibrinolysis during operation is a local response to trauma. Surgery, 123 (5), 539–544.
- Horbelt, D., Denkis, A., and Knaus, P., 2012. A portrait of transforming growth factor β superfamily signalling: background matters. The international journal of biochemistry & cell biology, 44 (3), 469–474.
- Hotamisligil, G.S., et al., 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science, 271 (5249), 665–670.
- Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M., 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259 (5091), 87–91.
- Hothersall, E., McSharry, C., and Thomson, N., 2006. Potential therapeutic role for statins in respiratory disease. Thorax, 61 (8), 729–734.
- Hu, B., et al., 2000. Coordinate induction of collagenase-1, stromelysin-1 and urokinase plasminogen activator (uPA) by the 120-kDa cell-binding fibronectin fragment in fibrocartilaginous cells: uPA contributes to activation of procollagenase-1. Matrix biology, 19 (7), 657–669.
- Jankovic, A., et al., 2015. Redox implications in adipose tissue (dys) function—a new look at old acquaintances. Redox biology, 6, 19–32.
- Kern, P.A., et al., 1995. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Journal of clinical investigation, 95 (5), 2111–2119.
- Kissebah, A.H., et al., 1982. Relation of body fat distribution to metabolic complications of obesity. Journal of clinical endocrinology and metabolism, 54 (2), 254–260.
- Laaksonen, D., et al., 2004. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia, 47 (8), 1403–1410.
- Lafontan, M., 2005. Fat cells: afferent and efferent messages define new approaches to treat obesity. Annual review of pharmacology and toxicology, 45 (1), 119–146.
- Lavrovsky, Y., et al., 2000. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Experimental gerontology, 35 (5), 521–532.
- Li, C., et al., 2004. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. American journal of physiology-renal physiology, 286 (1), F46–57.
- Liakakos, T., et al., 2001. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Digestive surgery, 18 (4), 260–273.
- McTernan, C.L., et al., 2002. Resistin, central obesity, and type 2 diabetes. The Lancet, 359 (9300), 46–47.
- Menzies, D., 1992. Peritoneal adhesions. Incidence, cause, and prevention. Surgery annual, 24, 27.
- Menzies, D. and Ellis, H., 1990. Intestinal obstruction from adhesions – how big is the problem? Annals of the royal college of surgeons of England, 72 (1), 60–63.
- Michailova, K.N. and Usunoff, K.G., 2006. Serosal membranes (pleura, pericardium, peritoneum): normal structure, development and experimental pathology. Vol. 183. Berlin: Springer Science & Business Media.
- Molinas, C.R., et al., 2003. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice. Fertility and sterility, 80 (1), 184–192.
- Nakamura, T., et al., 1994. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 107 (2), 239–246.
- Naugler, W.E. and Karin, M., 2008. The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in molecular medicine, 14 (3), 109–119.
- Nayor, M. and Vasan, R.S., 2016. Recent update to the US cholesterol treatment guidelines: a comparison with international guidelines. Circulation, 133 (18), 1795–1806.
- Nishibori, M., Takahashi, H.K., and Mori, S., 2003. The regulation of ICAM-1 and LFA-1 interaction by autacoids and statins: a novel strategy for controlling inflammation and immune responses. Journal of pharmacological sciences, 92 (1), 7–12.
- Nogueiras, R., et al., 2003. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obesity research, 11 (3), 408–414.
- Ou, X-m., et al., 2008. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice. Chinese medical journal, 121 (18), 1821–1829.
- Park, I.-H., et al., 2012. Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. American journal of rhinology & allergy, 26 (1), 7–11.
- Pismensky, S.V., et al., 2011. Severe inflammatory reaction induced by peritoneal trauma is the key driving mechanism of postoperative adhesion formation. BMC surgery, 11 (1), 30.
- Raftery, A.T., 1979. Regeneration of peritoneum: a fibrinolytic study. Journal of anatomy, 129 (Pt 3), 659–664.
- Reilly, M.P., et al., 2005. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111 (7), 932–939.
- Rodgers, K.E. and Dizerega, G.S., 1993. Function of peritoneal exudate cells after abdominal surgery. Journal of investigative surgery, 6 (1), 9–23.
- Samad, F., et al., 1997. Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Molecular medicine, 3 (1), 37–48.
- Sartipy, P. and Loskutoff, D.J., 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proceedings of the national academy of sciences of the United States of America, 100 (12), 7265–7270.
- Savage, D.B., et al., 2001. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes, 50 (10), 2199–2202.
- Sawdey, M. and Loskutoff, D., 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. Journal of clinical investigation, 88 (4), 1346–1353.
- Schönbeck, U. and Libby, P., 2004. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation, 109(21_suppl_1), II-18–II-26.
- Shimomura, I., et al., 1996. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature medicine, 2 (7), 800–803.
- Shoelson, S.E., Herrero, L., and Naaz, A., 2007. Obesity, inflammation, and insulin resistance. Gastroenterology, 132 (6), 2169–2180.
- Sies, H., 2015. Oxidative stress: a concept in redox biology and medicine. Redox biology, 4, 180–183.
- Simon, T.G., et al., 2015. Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C. Journal of hepatology, 62 (1), 18–23.
- Sulaiman, H., et al., 2000. Growth of nerve fibres into murine peritoneal adhesions. The journal of pathology, 192 (3), 396–403.
- Vaughan, D.E., 2005. PAI-1 and atherothrombosis. Journal of thrombosis and haemostasis, 3 (8), 1879–1883.
- Verrecchia, F., Chu, M.-L., and Mauviel, A., 2001. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. Journal of biological chemistry, 276 (20), 17058–17062.
- Wagner, A.H., Schwabe, O., and Hecker, M., 2002. Atorvastatin inhibition of cytokine‐inducible nitric oxide synthase expression in native endothelial cells in situ. British journal of pharmacology, 136 (1), 143–149.
- Wang, B. and Trayhurn, P., 2006. Acute and prolonged effects of TNF-α on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflügers archiv – European journal of physiology, 452 (4), 418–427.
- Watts, K.L., et al., 2005. Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts. American journal of respiratory cell and molecular biology, 32 (4), 290–300.
- Wei, G., et al., 2016. Effect of resveratrol on the prevention of intra-abdominal adhesion formation in a rat model. Cellular physiology and biochemistry, 39 (1), 33–46.
- Wei, J., Ma, C., and Wang, X., 2006. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 expression of glomerular mesangial cells in hypercholesterolemic rabbits. Biomedical research, 27 (4), 149–155.
- Weiner, F.R., et al., 1989. Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor. alpha. Biochemistry, 28 (9), 4094–4099.
- Weisberg, S.P., et al., 2003. Obesity is associated with macrophage accumulation in adipose tissue. Journal of clinical investigation, 112 (12), 1796–1808.
- Wiesbauer, F., et al., 2002. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins. British journal of pharmacology, 135 (1), 284–292.
- Xu, H., et al., 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of clinical investigation, 112 (12), 1821–1830.
- Yudkin, J., 2003. Adipose tissue, insulin action and vascular disease: inflammatory signals. International journal of obesity, 27 (S3), S25–S28.